Find Suplatast Tosilate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Suplatast tosylate, 94055-76-2, Ipd 1151t, Ipd-1151t, Suplatast (tosilate), Suplatasttosilate
Molecular Formula
C23H33NO7S2
Molecular Weight
499.6  g/mol
InChI Key
RYVJQEZJUFRANT-UHFFFAOYSA-N
FDA UNII
C9J89787U1

Suplatast Tosilate
1 2D Structure

Suplatast Tosilate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[3-[4-(3-ethoxy-2-hydroxypropoxy)anilino]-3-oxopropyl]-dimethylsulfanium;4-methylbenzenesulfonate
2.1.2 InChI
InChI=1S/C16H25NO4S.C7H8O3S/c1-4-20-11-14(18)12-21-15-7-5-13(6-8-15)17-16(19)9-10-22(2)3;1-6-2-4-7(5-3-6)11(8,9)10/h5-8,14,18H,4,9-12H2,1-3H3;2-5H,1H3,(H,8,9,10)
2.1.3 InChI Key
RYVJQEZJUFRANT-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCOCC(COC1=CC=C(C=C1)NC(=O)CC[S+](C)C)O.CC1=CC=C(C=C1)S(=O)(=O)[O-]
2.2 Other Identifiers
2.2.1 UNII
C9J89787U1
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (2-(4-(3-ethoxy-2-hydroxypropoxy)phenylcarbamoyl)ethyl)dimethylsulfonium P-toluenesulfonate

2. Ipd 1151t

3. Ipd-1151t

2.3.2 Depositor-Supplied Synonyms

1. Suplatast Tosylate

2. 94055-76-2

3. Ipd 1151t

4. Ipd-1151t

5. Suplatast (tosilate)

6. Suplatasttosilate

7. Suplatast Tosilate [inn]

8. 94055-76-2 (tosylate)

9. C9j89787u1

10. (3-((4-(3-ethoxy-2-hydroxypropoxy)phenyl)amino)-3-oxopropyl)dimethylsulfonium 4-methylbenzenesulfonate

11. Dsstox_cid_25003

12. Dsstox_rid_80646

13. Dsstox_gsid_45003

14. [3-[4-(3-ethoxy-2-hydroxypropoxy)anilino]-3-oxopropyl]-dimethylsulfanium;4-methylbenzenesulfonate

15. Sulfonium, (3-((4-(3-ethoxy-2-hydroxypropoxy)phenyl)amino)-3-oxopropyl)dimethyl-, Salt With 4-methylbenzenesulfonic Acid (1:1)

16. Suplatastum Tosilas

17. Cas-94055-76-2

18. Ccris 6596

19. Tosilate De Suplatast

20. Tosilato De Suplatast

21. Suplatastum Tosilas [inn-latin]

22. Ncgc00181000-01

23. Tosilate De Suplatast [inn-french]

24. Tosilato De Suplatast [inn-spanish]

25. Unii-c9j89787u1

26. [3-[[4-(3-ethoxy-2-hydroxypropoxy)phenyl]amino]-3-oxopropyl]dimethylsulfonium 4-methylbenzenesulfonate

27. Mfcd00867604

28. Ym-672

29. Ipd (tn)

30. (+-)-(2-(4-(3-ethoxy-2-hydroxypropoxy)phenyl)carbamoyl)ethyldimethylsulfonium P-tosylate

31. Schembl29042

32. Mls006010745

33. Suplatast Tosilate (jan/inn)

34. Chembl115435

35. Suplatast Tosylate [mi]

36. Dtxsid9045003

37. Suplatast Tosilate [jan]

38. Hms3413p08

39. Hms3655l09

40. Hms3677p08

41. Suplatast Tosilate [mart.]

42. Amy40561

43. Bcp10310

44. Suplatast Tosilate [who-dd]

45. Tox21_112652

46. S2015

47. Suplatast Tosylate, >=98% (hplc)

48. Akos015900359

49. Tox21_112652_1

50. Ccg-269685

51. Cs-0574

52. Ks-1288

53. Ncgc00181000-02

54. (+-)-(2-((p-(3-ethoxy-2-hydroxypropoxy)phenyl)carbamoyl)ethyl)dimethylsulfonium P-toluenesulfonate

55. Hy-17002

56. Smr004701701

57. Ft-0650625

58. S0875

59. Sw219352-1

60. C77240

61. D01423

62. Q7644399

63. 2-[4-(3-ethoxy-2-hydroxypropoxy)phenylcarbamoyl]ethyldimethylsulfonium P-toluenesulfonate

64. (3-(4-(3-ethoxy-2-hydroxypropoxy)phenylamino)-3-oxopropyl)dimethylsulfonium 4-methylbenzenesulfonate

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 499.6 g/mol
Molecular Formula C23H33NO7S2
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count7
Rotatable Bond Count10
Exact Mass499.16984474 g/mol
Monoisotopic Mass499.16984474 g/mol
Topological Polar Surface Area134 Ų
Heavy Atom Count33
Formal Charge0
Complexity500
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Allergic Agents

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)


Histamine Antagonists

Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)


API SUPPLIERS

read-more
read-more

01

Lifecare Laboratories Pvt Ltd

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLifecare Labs has been developing innovative products in specialist areas of medicine.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
LifeCare Laboratories

02

Taiho Pharmaceutical

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Pharma, Lab & Chemical Expo
Not Confirmed
arrow

Taiho Pharmaceutical

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
USDMF Inactive-api CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

03

IWAKI SEIYAKU

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Pharma, Lab & Chemical Expo
Not Confirmed
arrow

IWAKI SEIYAKU

Japan

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-more

01

Pharma, Lab & Chemical Expo
Not Confirmed

01

Pharma, Lab & Chemical Expo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 17336

Submission : 2004-04-12

Status : Inactive

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

arrow
Pharma, Lab & Chemical Expo
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLifecare Labs has been developing innovative products in specialist areas of medicine.

Flag India
Digital Content Digital Content

Suplatast Tosilate

About the Company : Lifecare Labs specializes in producing bulk drugs (APIs) and intermediates that adhere to the industry's stringent quality parameters. Its objective is to deliver excellence throug...

Lifecare Labs specializes in producing bulk drugs (APIs) and intermediates that adhere to the industry's stringent quality parameters. Its objective is to deliver excellence through its "quality designed for excellence" mission and meet its customers' requirements. Cost-effectiveness is a top priority for the company, and it aims to establish long-term relationships with its clients. Lifecare Labs possesses state-of-the-art facilities for manufacturing bulk drugs (APIs) and intermediates and has dedicated units for products. Its mission is to become a globally recognized company responsible for its customers, business partners and society.
LifeCare Laboratories

02

Pharma, Lab & Chemical Expo
Not Confirmed
arrow
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

Suplatast Tosilate

About the Company : With “Health for Humanity” and “Infinite Possibilities of the Development of Chemical Science and Technology” as our visions, Iwaki Seiyaku Company Ltd. has been always str...

With “Health for Humanity” and “Infinite Possibilities of the Development of Chemical Science and Technology” as our visions, Iwaki Seiyaku Company Ltd. has been always striving to meet the needs of the new era. Our goal is to contribute to our society through innovation and diligent progress. Formulations Active Pharmaceutical Ingredients Specialty Chemicals  This triangular foundation supports the robustness of our business.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Suplatast Tosilate Manufacturers

A Suplatast Tosilate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Suplatast Tosilate, including repackagers and relabelers. The FDA regulates Suplatast Tosilate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Suplatast Tosilate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Suplatast Tosilate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Suplatast Tosilate Suppliers

A Suplatast Tosilate supplier is an individual or a company that provides Suplatast Tosilate active pharmaceutical ingredient (API) or Suplatast Tosilate finished formulations upon request. The Suplatast Tosilate suppliers may include Suplatast Tosilate API manufacturers, exporters, distributors and traders.

click here to find a list of Suplatast Tosilate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Suplatast Tosilate USDMF

A Suplatast Tosilate DMF (Drug Master File) is a document detailing the whole manufacturing process of Suplatast Tosilate active pharmaceutical ingredient (API) in detail. Different forms of Suplatast Tosilate DMFs exist exist since differing nations have different regulations, such as Suplatast Tosilate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Suplatast Tosilate DMF submitted to regulatory agencies in the US is known as a USDMF. Suplatast Tosilate USDMF includes data on Suplatast Tosilate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Suplatast Tosilate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Suplatast Tosilate suppliers with USDMF on PharmaCompass.

Suplatast Tosilate GMP

Suplatast Tosilate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Suplatast Tosilate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Suplatast Tosilate GMP manufacturer or Suplatast Tosilate GMP API supplier for your needs.

Suplatast Tosilate CoA

A Suplatast Tosilate CoA (Certificate of Analysis) is a formal document that attests to Suplatast Tosilate's compliance with Suplatast Tosilate specifications and serves as a tool for batch-level quality control.

Suplatast Tosilate CoA mostly includes findings from lab analyses of a specific batch. For each Suplatast Tosilate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Suplatast Tosilate may be tested according to a variety of international standards, such as European Pharmacopoeia (Suplatast Tosilate EP), Suplatast Tosilate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Suplatast Tosilate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty